MENU
ZLAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Zai Lab (ZLAB) Earnings Date & Reports

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ZLAB is expected to report earnings to fall 53.67% to -15 cents per share on March 03

Zai Lab ZLAB Stock Earnings Reports
Q4'25
Est.
$-0.15
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.37
Q1'25
Beat
by $0.42
Q4'24
Beat
by $0.65
The last earnings report on November 06 showed earnings per share of -33 cents, missing the estimate of -25 cents. With 211.19K shares outstanding, the current market capitalization sits at 2.45B.
View a ticker or compare two or three
ZLAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZLAB showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a service for cancer & autoimmune treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4560 Jinke Road
Phone
+86 2161632588
Employees
2175
Web
https://www.zailaboratory.com